EndosleeveNCT03554902
Endoscopic Gastric Tubulization
At risk: Primary completion moved at least 1 year 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 5 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Jun 2028 to Jun 2030 Show 4 more changesShow less
- Eligibility criteria expanded, about 1 word
- Secondary endpoints: details revised at 3 of 9 entries
- Site contact updated
- Publications: details revised at 5 of 5 entries
- Notable Primary and study completion dates pushed to Jun 2028v7
- Notable Enrollment target: 100 to 300
- Primary completion date: Jun 2022 to Jun 2024
- Study completion date: Jun 2022 to Jun 2026
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jun 2018 to Jun 8, 2018
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change in weight loss
Timeframe: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
Change in excess weight loss
Timeframe: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
Change in body mass index variation
Timeframe: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
Secondary (9)
Number of patients with procedure-related adverse event
Comorbidities improvement
Quality of life improvement
Gastro-intestinal quality of life improvement
Modification in the feeling of satiety
Show 4 moreShow less
Upper GI tract radiologic evaluation
Upper GI tract endoscopic evaluation
Procedure duration
Number of stitches in place
Arms and interventions
Endoscopic gastric tubulization
Endoscopic gastric tubulization is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA).
Procedures: Endoscopic gastric tubulization
Sites
1 site in 1 country
- Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital CivilStrasbourg, France